Timeline

Key events during the development of the guidance:

Date Update
09 December 2024 Pre-consultation documents released
07 November 2024 - 21 November 2024 Draft scope consultation
06 November 2024 Stakeholder list updated
11 October 2024 Committee meeting: Scoping meeting 1
03 October 2024 This update will cover: Ovarian Function Suppression, Chemotherapy for Advanced Breast Cancer and Biological Therapy for Advanced Breast Cancer

For further information on the guideline development process, please see how we develop NICE guidelines